Phase III SEQUOIA-HCM analyses show aficamten offers benefit to patients with varying symptom severity and across regions, opening …
Phase III SEQUOIA-HCM analyses show aficamten offers benefit to patients with varying symptom severity and across regions, opening …
New oral vaccine succeeds against multiple cholera strains offering promise for broad use in endemic regions
A new antibody-drug conjugate brings hope for patients with lung cancer who have few options
Combination therapy delivers promising efficacy and manageable safety in PD-1 refractory head and neck squamous cell carcinoma
Trial halt and valuation collapse trigger major workforce reduction at fibrosis-focused biotech
New safety and efficacy evidence supports expanded use of mavacamten in oHCM patients
The World Health Organization galvanized global efforts to make clinical trials faster, more inclusive, and deeply rooted in …
Targeted treatment approach shows potential to reshape how antidepressants are prescribed
Two key developments in US oncology signal faster progress: a new standard therapy for aggressive colorectal cancer and …
Prime Minister Starmer unveils ambitious reforms to speed up trial timelines and centralize NHS data, aiming to restore …
Already a subscriber? Log in